{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:04:59Z","timestamp":1789473899338,"version":"build-2803163510"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Platelet-rich plasma (PRP) has emerged as a widely applied autologous biologic therapy in musculoskeletal medicine. Its concentrated growth factor content is postulated to promote tissue regeneration, modulate the inflammatory cascade, and provide clinically meaningful and durable symptom relief in both degenerative joint disease and chronic tendinopathy. Despite its widespread clinical adoption, the evidence base remains heterogeneous, and its rational application requires a critical synthesis of current findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This narrative review aimed to critically examine the existing clinical evidence for PRP in the management of degenerative joint disorders and soft tissue conditions, to evaluate indication-specific efficacy, and to provide evidence-based clinical recommendations for its use in musculoskeletal practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A narrative review of the literature was undertaken, with searches of Medline (via PubMed), Embase, and the Cochrane Database of Systematic Reviews for relevant publications up to July 2025. Randomized controlled trials (RCTs), systematic reviews, and meta-analyses comparing PRP with active comparators or placebo in osteoarthritis or tendinopathy were selected based on clinical relevance, sample size, and follow-up duration. No formal protocol registration, dual independent screening, or risk-of-bias scoring was applied; the synthesis is therefore interpretive rather than systematic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>PRP may provide clinically meaningful symptom improvement in selected patients with mild-to-moderate knee and hip osteoarthritis, where modest advantages over hyaluronic acid are reported in some studies and medium-term outcomes may be more durable than with corticosteroid, particularly with leukocyte-poor PRP (LP-PRP) delivered as a series of two to three injections. Among soft tissue conditions, PRP appears most useful relative to corticosteroid in plantar fasciitis, degenerative rotator cuff disease, and trochanteric tendinopathy. Evidence in lateral epicondylitis is mixed: PRP outperforms corticosteroid in the medium term, but placebo-controlled data do not demonstrate a clinically important effect. Current evidence does not support PRP for Achilles tendinopathy, and placebo-controlled data also challenge its use in ankle osteoarthritis. The therapeutic effect of PRP is characteristically delayed, emerging at eight to sixteen weeks and persisting up to eighteen to twenty-four months in selected indications; however, the certainty of evidence varies substantially by indication, comparator, PRP formulation, and follow-up duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PRP may represent a reasonable second-line treatment option for selected musculoskeletal conditions, particularly after insufficient response to structured conservative management. The strength of evidence is highly indication-dependent and is weakest precisely where placebo-controlled data exist. Standardization of PRP preparation and reporting, and rigorous placebo-controlled trials in indications where these are lacking, are essential to advance the evidence base.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1920226","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:34:51Z","timestamp":1789472091000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet-rich plasma in the management of musculoskeletal disorders: a narrative review of clinical evidence and practical considerations"],"prefix":"10.3389","volume":"13","author":[{"given":"Stavros","family":"Litsos","sequence":"first","affiliation":[{"name":"House of Health","place":["Oslo, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas P.","family":"Diamantopoulos","sequence":"additional","affiliation":[{"name":"Rheumatology, Akershus University Hospital","place":["L\u00f8renskog, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Molund","sequence":"additional","affiliation":[{"name":"Sykehuset \u00d8stfold HF","place":["Gr\u00e5lum, Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/JSM.0000000000000973","article-title":"American Medical Society for sports medicine position statement: principles for the responsible use of regenerative medicine in sports medicine","volume":"31","author":"Finnoff","year":"2021","journal-title":"Clin J Sport Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/0363546518814532","article-title":"Platelet-rich plasma versus hyaluronic acid injections for the treatment of knee osteoarthritis: results at 5 years of a double-blind, randomized controlled trial","volume":"47","author":"Di Martino","year":"2019","journal-title":"Am J Sports Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1136\/annrheumdis-2021-220266","article-title":"EULAR recommendations for intra-articular therapies","volume":"80","author":"Uson","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10195-018-0501-3","article-title":"Clinical and radiographic comparison of a single LP-PRP injection, a single hyaluronic acid injection and daily NSAID administration with a 52-week follow-up: a randomized controlled trial","volume":"19","author":"Buend\u00eda-L\u00f3pez","year":"2018","journal-title":"J Orthop Traumatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1051\/ject\/200638174","article-title":"Platelet-rich plasma and platelet gel: a review","volume":"38","author":"Everts","year":"2006","journal-title":"J Extra Corpor Technol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1177\/0363546511404877","article-title":"One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial","volume":"39","author":"de Jonge","year":"2011","journal-title":"Am J Sports Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1007\/s00590-023-03570-6","article-title":"Platelet-rich plasma in chronic Achilles tendinopathy","volume":"33","author":"Desouza","year":"2023","journal-title":"Eur J Orthop Surg Traumatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/PHM.0000000000002677","article-title":"Platelet-rich plasma versus corticosteroids in the treatment of plantar fasciitis: a systematic review and meta-analysis","volume":"104","author":"Zuo","year":"2025","journal-title":"Am J Phys Med Rehabil."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.22374\/boj.v4iSP1.47","article-title":"The effects of platelet-rich plasma in conjunction with rehabilitation for lower extremity musculoskeletal pathologies: a systematic review with meta-analysis","volume":"4","author":"Masaracchio","year":"2022","journal-title":"Biol Orthop J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/JPR.S204788","article-title":"MRI changes after platelet rich plasma injection in knee osteoarthritis (randomized clinical trial)","volume":"13","author":"Raeissadat","year":"2020","journal-title":"J Pain Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.3390\/jcm14082714","volume":"14","author":"Corsini","year":"2025","journal-title":"J Clin Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/ksa.12077","article-title":"The use of injectable orthobiologics for knee osteoarthritis: a European ESSKA-ORBIT consensus. Part 1-Blood-derived products (platelet-rich plasma)","volume":"32","author":"Laver","year":"2024","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1177\/0363546519826969","article-title":"Leucocyte-rich platelet-rich plasma treatment of gluteus medius and minimus tendinopathy: a double-blind randomized controlled trial with 2-year follow-up","volume":"47","author":"Fitzpatrick","year":"2019","journal-title":"Am J Sports Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.arthro.2020.07.011","article-title":"Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis of 26 randomized controlled trials","volume":"37","author":"Tan","year":"2021","journal-title":"Arthroscopy."},{"key":"B15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.arthro.2016.09.024","article-title":"Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials","volume":"33","author":"Dai","year":"2017","journal-title":"Arthroscopy"},{"key":"B16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13018-024-04736-6","article-title":"The varying clinical effectiveness of single, three and five intraarticular injections of platelet-rich plasma in knee osteoarthritis","volume":"19","author":"Zhuang","year":"2024","journal-title":"J Orthop Surg Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1016\/j.arthro.2023.05.018","article-title":"Three doses of platelet-rich plasma therapy are more effective than one dose of platelet-rich plasma in the treatment of knee osteoarthritis: a systematic review and meta-analysis","volume":"39","author":"Tao","year":"2023","journal-title":"Arthroscopy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s43465-021-00459-6","article-title":"A role of triple injection platelet-rich plasma for osteoarthritis knees: a 2 years follow-up study","volume":"56","author":"Huda","year":"2021","journal-title":"Indian J Orthop."},{"key":"B19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1097\/RLI.0000000000001067","article-title":"Morphological and quantitative parametric MRI follow-up of cartilage changes before and after intra-articular injection therapy in patients with mild to moderate knee osteoarthritis: a randomized, placebo-controlled trial","volume":"59","author":"Tschopp","year":"2024","journal-title":"Invest Radiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/1756-185X.13315","article-title":"Clinical outcomes are associated with changes in ultrasonographic structural appearance after platelet-rich plasma treatment for knee osteoarthritis","volume":"21","author":"Ahmad","year":"2018","journal-title":"Int J Rheum Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.joca.2021.09.010","article-title":"How does hip osteoarthritis differ from knee osteoarthritis?","volume":"30","author":"Hall","year":"2022","journal-title":"Osteoarthritis Cartilage."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s12325-016-0409-3","article-title":"Hip osteoarthritis: etiopathogenesis and implications for management","volume":"33","author":"Murphy","year":"2016","journal-title":"Adv Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-025-00594-6","article-title":"Osteoarthritis","volume":"11","author":"Tang","year":"2025","journal-title":"Nat Rev Dis Primers."},{"key":"B25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1177\/0363546515620383","article-title":"Ultrasound-guided injection of platelet-rich plasma and hyaluronic acid, separately and in combination, for hip osteoarthritis: a randomized controlled study","volume":"44","author":"Dallari","year":"2016","journal-title":"Am J Sports Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e1501-8","DOI":"10.3928\/01477447-20131120-13","article-title":"Efficacy of ultrasound-guided intra-articular injections of platelet-rich plasma versus hyaluronic acid for hip osteoarthritis","volume":"36","author":"Battaglia","year":"2013","journal-title":"Orthopedics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1177\/03635465221095563","article-title":"The use of intra-articular platelet-rich plasma as a therapeutic intervention for hip osteoarthritis: a systematic review and meta-analysis","volume":"51","author":"Lim","year":"2023","journal-title":"Am J Sports Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1177\/0363546520937293","article-title":"Platelet-rich plasma versus corticosteroids for the treatment of plantar fasciitis: a systematic review and meta-analysis","volume":"49","author":"Hohmann","year":"2021","journal-title":"Am J Sports Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e20560","DOI":"10.7759\/cureus.20560","article-title":"Comparison of functional outcome between intra-articular injection of corticosteroid versus platelet-rich plasma in frozen shoulder: a randomized controlled trial","volume":"13","author":"Shahzad","year":"2021","journal-title":"Cureus"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e39728","DOI":"10.7759\/cureus.39728","article-title":"Comparing the efficacy of intra-articular platelet-rich plasma and corticosteroid injections in the management of frozen shoulder: a randomized controlled trial","volume":"15","author":"Somisetty","year":"2023","journal-title":"Cureus."},{"key":"B31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1530\/EOR-22-0104","article-title":"The role of platelet-rich plasma in shoulder pathologies: a critical review of the literature","volume":"8","author":"Rosso","year":"2023","journal-title":"EFORT Open Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1001\/jama.2021.16602","article-title":"Effect of platelet-rich plasma injections vs placebo on ankle symptoms and function in patients with ankle osteoarthritis: a randomized clinical trial","volume":"326","author":"Paget","year":"2021","journal-title":"JAMA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1177\/03635465231182438","article-title":"Platelet-rich plasma injections for the treatment of ankle osteoarthritis","volume":"51","author":"Paget","year":"2023","journal-title":"Am J Sports Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13018-023-03828-z","article-title":"Platelet-rich plasma injection for the treatment of ankle osteoarthritis: a systematic review and meta-analysis","volume":"18","author":"Laohajaroensombat","year":"2023","journal-title":"J Orthop Surg Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1177\/1071100718779375","article-title":"Intra-articular injections in the treatment of symptoms from ankle arthritis: a systematic review","volume":"39","author":"Vannabouathong","year":"2018","journal-title":"Foot Ankle Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.18231\/j.ijor.2020.019","article-title":"PRP in acromio-clavicular joint arthritis \u2013 A prospective analysis","volume":"6","author":"Raja","year":"2021","journal-title":"IP Int J Orthopaedic Rheumatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1947603518805230","article-title":"Platelet-rich plasma versus corticosteroid intra-articular injections for the treatment of trapeziometacarpal arthritis: a prospective randomized controlled clinical trial","volume":"12","author":"Malahias","year":"2021","journal-title":"Cartilage."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e29253","DOI":"10.7759\/cureus.29253","article-title":"Comparison of the efficacy of platelet-rich plasma (PRP) and local corticosteroid injection in periarthritis shoulder: a prospective, randomized, open, blinded end-point (PROBE) study","volume":"14","author":"Gupta","year":"2022","journal-title":"Cureus"},{"key":"B39","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00256-023-04373-w","article-title":"Effectiveness of single intra-bursal injection of platelet-rich plasma against corticosteroid under ultrasonography guidance for shoulder impingement syndrome: a randomized clinical trial","volume":"53","author":"Hewavithana","year":"2024","journal-title":"Skeletal Radiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/0363546513494359","article-title":"Efficacy of platelet-rich plasma for chronic tennis elbow: a double-blind, prospective, multicenter, randomized controlled trial of 230 patients using a single spin system","volume":"42","author":"Mishra","year":"2014","journal-title":"Am J Sports Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"CD010951","DOI":"10.1002\/14651858.CD010951.pub2","article-title":"Autologous blood and platelet-rich plasma injection therapy for lateral elbow pain","volume":"30","author":"Karjalainen","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5606\/tftrd.2021.6377","article-title":"Comparison of platelet-rich plasma and extracorporeal shock wave therapy in patients with chronic lateral epicondylitis: a prospective, randomized-controlled study","volume":"67","author":"Sahbaz","year":"2021","journal-title":"Turk J Phys Med Rehabil."},{"key":"B43","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jor.2018.01.046","article-title":"Platelet rich plasma injections for lateral epicondylitis of the elbow reduce the need for surgical intervention","volume":"15","author":"Hastie","year":"2018","journal-title":"J Orthop."},{"key":"B44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5005\/jp-journals-10040-1368","article-title":"Healing heels: a meta-analysis of platelet-rich plasma vs corticosteroid injections in plantar fasciitis treatment","volume":"11","author":"Shetty","year":"2024","journal-title":"J Foot Ankle Surg."},{"key":"B45","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s43465-020-00261-w","article-title":"Role of platelet rich plasma in chronic plantar fasciitis: a prospective study","volume":"55","author":"Kalia","year":"2020","journal-title":"Indian J Orthop"},{"key":"B46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5397\/cise.2021.00486","article-title":"Platelet-rich plasma versus corticosteroid injections for rotator cuff tendinopathy: a comparative study with up to 18-month follow-up","volume":"25","author":"Annaniemi","year":"2022","journal-title":"Clin Shoulder Elb."},{"key":"B47","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jse.2022.08.017","article-title":"Plasma rich in growth factors versus corticosteroid injections for management of chronic rotator cuff tendinopathy: a prospective double-blind randomized controlled trial with 1 year of follow-up","volume":"32","author":"Vaquerizo","year":"2023","journal-title":"J Shoulder Elbow Surg."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.jse.2024.06.012","article-title":"Subacromial injection of platelet-rich plasma provides greater improvement in pain and functional outcomes compared to corticosteroids at 1-year follow-up: a double-blinded randomized controlled trial","volume":"33","author":"Rossi","year":"2024","journal-title":"J Shoulder Elbow Surg."},{"key":"B49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/sports12020046","article-title":"The best current research on patellar tendinopathy: a review of published meta-analyses","volume":"12","author":"Llombart","year":"2024","journal-title":"Sports."},{"key":"B50","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1177\/0363546513518416","article-title":"Platelet-rich plasma as a treatment for patellar tendinopathy: a double-blind, randomized controlled trial","volume":"42","author":"Dragoo","year":"2014","journal-title":"Am J Sports Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5792\/ksrr.16.055","article-title":"Platelet-rich plasma injections as a treatment for refractory patellar tendinosis: a meta-analysis of randomised trials","volume":"29","author":"Dupley","year":"2017","journal-title":"Knee Surg Relat Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1177\/0363546519837954","article-title":"Platelet-rich plasma for patellar tendinopathy: a randomized controlled trial of leukocyte-rich PRP or leukocyte-poor PRP versus saline","volume":"47","author":"Scott","year":"2019","journal-title":"Am J Sports Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e15278","DOI":"10.1097\/MD.0000000000015278","article-title":"Platelet-rich plasma injection for the treatment of chronic Achilles tendinopathy : a meta-analysis","volume":"98","author":"Liu","year":"2019","journal-title":"Medicine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.amsu.2020.04.042","article-title":"The use of PRP in treatment of Achilles tendinopathy: a systematic review of literature. Study design: Systematic review of literature","volume":"55","author":"Madhi","year":"2020","journal-title":"Ann Med Surg."},{"key":"B55","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jama.2021.16067","article-title":"Effect of platelet-rich plasma injection vs sham injection on tendon dysfunction in patients with chronic midportion achilles tendinopathy: a randomized clinical trial","volume":"326","author":"Kearney","year":"2021","journal-title":"JAMA."},{"key":"B56","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/jcm12030995","article-title":"The efficacy of platelet-rich plasma injection therapy in the treatment of patients with achilles tendinopathy: a systematic review and meta-analysis","volume":"12","author":"Arthur Vithran","year":"2023","journal-title":"J Clin Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"23259671241276368","DOI":"10.1177\/23259671241276368","article-title":"Clinical effects of additional platelet-rich plasma application to exercise therapy in patients with subacromial impingement syndrome: a double-blind randomized controlled trial","volume":"12","author":"Ziroglu","year":"2024","journal-title":"Orthop J Sports Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.arthro.2023.08.020","article-title":"Experts achieve consensus on a majority of statements regarding platelet-rich plasma treatments for treatment of musculoskeletal pathology","volume":"40","author":"Hurley","year":"2024","journal-title":"Arthroscopy"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/j.arthro.2023.03.022","article-title":"Editorial commentary: platelet-rich plasma injections produced a significant improvement in most patients with rotator cuff tendinopathy","volume":"39","author":"Hurley","year":"2023","journal-title":"Arthroscopy."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.joca.2019.06.011","article-title":"OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis","volume":"27","author":"Bannuru","year":"2019","journal-title":"Osteoarthritis Cartilage."},{"key":"B61","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","article-title":"2019 American College of Rheumatology\/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip, and knee","volume":"72","author":"Kolasinski","year":"2020","journal-title":"Arthritis Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1920226\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:34:52Z","timestamp":1789472092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1920226\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":61,"alternative-id":["10.3389\/fmed.2026.1920226"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1920226","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1920226"}}